Omnicell

SEPTEMBER 5, 2022

Scott Seidelmann EVP and Chief Commercial Officer, Omnicell As COVID-19 continues to impact healthcare across the care continuum, the need for solutions designed to help providers achieve greater visibility, control costs, and better manage an increasingly complex pharmacy supply chain is more important than ever.

Omnicell 52

Omnicell Documentation Patient Care 52

Omnicell

JANUARY 10, 2023

Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell Imagine if Amazon lost one out of every 10 packages. So why, as clinicians, are we not focused on improving the documented one in 10 inaccuracies in sterile compounded products? Or the airlines lost 10% of passenger bags.

Sterile Compounds 52

Sterile Compounds Compounding Omnicell Documentation 52

Omnicell

MARCH 27, 2023

The event provided 340B stakeholders with the opportunity to attend educational sessions and network with peers to address program challenges and exchange insights, ideas, and success stories. Omnicell can be a valued partner in this effort. These restrictions are also causing hardships for CEs and 340B program administrators.

Omnicell 52

Omnicell Specialty Pharmacies Community Pharmacies Documentation 52

Omnicell

SEPTEMBER 5, 2022

There are additional complications that arise from hyper-vigilante manual processes that can sometimes result in false positives and uncomfortable staff conversations due to documentation errors.

Controlled Substances 52

Controlled Substances Hospitals Documentation 52